Cargando…
Current progress in the development of a prophylactic vaccine for HIV-1
Since its discovery and characterization in the early 1980s as a virus that attacks the immune system, there has been some success for the treatment of human immunodeficiency virus-1 (HIV-1) infection. However, due to the overwhelming public health impact of this virus, a vaccine is needed urgently....
Autores principales: | Gamble, Lena J, Matthews, Qiana L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023272/ https://www.ncbi.nlm.nih.gov/pubmed/21267356 http://dx.doi.org/10.2147/DDDT.S6959 |
Ejemplares similares
-
Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines
por: Borovjagin, Anton V., et al.
Publicado: (2014) -
Current progress in the development of prophylactic and therapeutic vaccines
por: Li, Tingting, et al.
Publicado: (2022) -
Development of prophylactic vaccines against HIV-1
por: Schiffner, Torben, et al.
Publicado: (2013) -
HIV-1 prophylactic vaccines: state of the art
por: Lelièvre, Jean-Daniel, et al.
Publicado: (2016) -
An HIV/AIDS Prophylactic vaccine is possible
por: Zhong, Qiu, et al.
Publicado: (2007)